Trevi Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.20
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.13
|
-0.12
|
0.01
|
7.69%
|
|
2022-06-30
|
-0.18
|
-0.14
|
0.04
|
22.22%
|
|
2022-03-31
|
-0.29
|
-0.24
|
0.05
|
17.24%
|
|
2021-12-31
|
-0.30
|
-0.28
|
0.02
|
6.67%
|
|
2021-09-30
|
-0.40
|
-0.34
|
0.06
|
15.00%
|
|
2021-06-30
|
-0.46
|
-0.47
|
-0.01
|
-2.17%
|
|
2021-03-31
|
-0.52
|
-0.43
|
0.09
|
17.31%
|
|
2020-12-31
|
-0.44
|
-0.51
|
-0.07
|
-15.91%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.50
|
|
2021-12-31
|
-1.52
|
|
2020-12-31
|
-1.81
|
|
2019-12-31
|
-15.26
|
|
2018-12-31
|
-0.23
|